制定用户指南,以支持MRC朊病毒疾病分级量表在朊病毒疾病的研究和临床环境中的管理。

IF 1.6 3区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Prion Pub Date : 2025-12-01 Epub Date: 2025-09-30 DOI:10.1080/19336896.2025.2565204
Robert S Pulido, Chris Marshall, Anne V Smith, Hannah Edge, Aaron Yarlas, Brian Appleby, Jean-Philippe Brandel, Steven Collins, Nurit Omer, Inga Zerr, Simon Mead
{"title":"制定用户指南,以支持MRC朊病毒疾病分级量表在朊病毒疾病的研究和临床环境中的管理。","authors":"Robert S Pulido, Chris Marshall, Anne V Smith, Hannah Edge, Aaron Yarlas, Brian Appleby, Jean-Philippe Brandel, Steven Collins, Nurit Omer, Inga Zerr, Simon Mead","doi":"10.1080/19336896.2025.2565204","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prion diseases (PrD) are a group of progressive, fatal, neurodegenerative diseases, for which the Medical Research Council Prion Disease Rating Scale (MRC Scale) can be used to assess patients' functional deterioration. Findings from previous qualitative interviews with caregivers and clinical experts identified potential ambiguities in the scale that could lead to inconsistent scoring within and/or between raters.</p><p><strong>Methods: </strong>A draft User Guide was developed based on findings from a previous qualitative study. The draft included clarifications regarding domain wording, scoring levels, and guidance for response option selection. Five clinical experts with PrD management experience provided written feedback on the draft User Guide, which was incorporated into a revised User Guide. A 90-minute consensus meeting was then held with these experts to confirm the final content to be included in the User Guide.</p><p><strong>Results: </strong>The final User Guide was designed to accompany the MRC Scale and assist with rater decisions related to which response option most accurately describes a patient's health status. Conclusions: The User Guide is expected to be a valuable complement to the MRC Scale, which is poised to rise in use and prominence as global clinical research efforts accelerate to address the significant unmet need of PrD patients.</p>","PeriodicalId":54585,"journal":{"name":"Prion","volume":"19 1","pages":"1-7"},"PeriodicalIF":1.6000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489992/pdf/","citationCount":"0","resultStr":"{\"title\":\"Development of a user guide to support administration of the MRC Prion Disease Rating Scale in research and clinical settings for prion diseases.\",\"authors\":\"Robert S Pulido, Chris Marshall, Anne V Smith, Hannah Edge, Aaron Yarlas, Brian Appleby, Jean-Philippe Brandel, Steven Collins, Nurit Omer, Inga Zerr, Simon Mead\",\"doi\":\"10.1080/19336896.2025.2565204\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The prion diseases (PrD) are a group of progressive, fatal, neurodegenerative diseases, for which the Medical Research Council Prion Disease Rating Scale (MRC Scale) can be used to assess patients' functional deterioration. Findings from previous qualitative interviews with caregivers and clinical experts identified potential ambiguities in the scale that could lead to inconsistent scoring within and/or between raters.</p><p><strong>Methods: </strong>A draft User Guide was developed based on findings from a previous qualitative study. The draft included clarifications regarding domain wording, scoring levels, and guidance for response option selection. Five clinical experts with PrD management experience provided written feedback on the draft User Guide, which was incorporated into a revised User Guide. A 90-minute consensus meeting was then held with these experts to confirm the final content to be included in the User Guide.</p><p><strong>Results: </strong>The final User Guide was designed to accompany the MRC Scale and assist with rater decisions related to which response option most accurately describes a patient's health status. Conclusions: The User Guide is expected to be a valuable complement to the MRC Scale, which is poised to rise in use and prominence as global clinical research efforts accelerate to address the significant unmet need of PrD patients.</p>\",\"PeriodicalId\":54585,\"journal\":{\"name\":\"Prion\",\"volume\":\"19 1\",\"pages\":\"1-7\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489992/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prion\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1080/19336896.2025.2565204\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prion","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/19336896.2025.2565204","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:朊病毒疾病(PrD)是一组进行性、致死性、神经退行性疾病,医学研究委员会朊病毒疾病评定量表(MRC量表)可用于评定患者功能恶化程度。从先前对护理人员和临床专家的定性访谈中发现,量表中存在潜在的模糊性,可能导致评分者内部和/或评分者之间的评分不一致。方法:根据先前定性研究的结果,制定了一份用户指南草案。该草案包括关于领域措辞、评分水平和响应选项选择指导的澄清。5位具有PrD管理经验的临床专家就用户指南草案提供了书面反馈,该草案已被纳入修订后的用户指南。然后与这些专家举行了90分钟的协商一致会议,以确认将列入用户指南的最终内容。结果:最终用户指南的设计是为了配合MRC量表,并协助评分者决定哪种反应选项最准确地描述了患者的健康状况。结论:用户指南有望成为MRC量表的一个有价值的补充,随着全球临床研究努力加快,以解决PrD患者未满足的重大需求,MRC量表的使用和重要性将会上升。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Development of a user guide to support administration of the MRC Prion Disease Rating Scale in research and clinical settings for prion diseases.

Background: The prion diseases (PrD) are a group of progressive, fatal, neurodegenerative diseases, for which the Medical Research Council Prion Disease Rating Scale (MRC Scale) can be used to assess patients' functional deterioration. Findings from previous qualitative interviews with caregivers and clinical experts identified potential ambiguities in the scale that could lead to inconsistent scoring within and/or between raters.

Methods: A draft User Guide was developed based on findings from a previous qualitative study. The draft included clarifications regarding domain wording, scoring levels, and guidance for response option selection. Five clinical experts with PrD management experience provided written feedback on the draft User Guide, which was incorporated into a revised User Guide. A 90-minute consensus meeting was then held with these experts to confirm the final content to be included in the User Guide.

Results: The final User Guide was designed to accompany the MRC Scale and assist with rater decisions related to which response option most accurately describes a patient's health status. Conclusions: The User Guide is expected to be a valuable complement to the MRC Scale, which is poised to rise in use and prominence as global clinical research efforts accelerate to address the significant unmet need of PrD patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Prion
Prion 生物-生化与分子生物学
CiteScore
5.20
自引率
4.30%
发文量
13
审稿时长
6-12 weeks
期刊介绍: Prion is the first international peer-reviewed open access journal to focus exclusively on protein folding and misfolding, protein assembly disorders, protein-based and structural inheritance. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The overriding criteria for publication in Prion are originality, scientific merit and general interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信